Suppr超能文献

双胍类药物可诱导人原代皮脂细胞发生急性从头脂肪生成。

Biguanides Induce Acute de novo Lipogenesis in Human Primary Sebocytes.

作者信息

Nicoll James, Buehrer Benjamin M

机构信息

Zen-Bio, Inc., Research Triangle Park, NC, USA.

出版信息

Clin Cosmet Investig Dermatol. 2020 Feb 24;13:197-207. doi: 10.2147/CCID.S243154. eCollection 2020.

Abstract

INTRODUCTION

Acne arises during puberty, in part, due to elevated hormones and growth factors which stimulate de novo lipogenesis (DNL) in primary sebocytes to significantly increase sebum production. Oral isotretinoin is an effective acne therapy, reducing sebum production through inducing apoptosis in sebocytes. However, isotretinoin is teratogenic and has additional unwanted side effects, including an initial acne flare-up, which limits its utility. The biguanide, metformin has been found to alleviate severe acne in women with polycystic ovary syndrome (PCOS) through normalization of their insulin and androgen hormone levels. Metformin's broader effectiveness to improve acne in non-PCOS populations lacks significant clinical support. In an effort to determine whether biguanides directly affect sebogenesis, we investigated their ability to alter DNL in cell-based assays in vitro.

METHODS

De novo lipogenesis was measured in human primary sebocytes using [14C]-acetate labeling. Lipid species analysis was performed by extracting newly synthesized lipids and subjecting them to thin layer chromatography. Gene expression changes in sebocytes were identified through qPCR analysis of isolated RNA. Metabolic parameters including oxygen consumption rate, lactate production and activation of adenosine monophosphate-dependent protein kinase (AMPK) were assessed in human primary sebocytes.

RESULTS

Using human primary sebocytes, we found that biguanides, isotretinoin and azithromycin induced an acute dose and time-dependent increase in [14C]-acetate labeling of neutral lipids, while AICAR, an AMPK activator, inhibited this DNL response. Biguanides did not activate AMPK in sebocytes, however, they significantly reduced oxygen consumption rate and increased lactate production. Treatment with biguanides, but not isotretinoin, significantly upregulated ACSS2 gene expression in primary sebocytes and showed synergism with lipogenic activators to induce DNL genes.

DISCUSSION

These changes are consistent with an acute increase in sebocyte lipogenesis and support the potential of biguanides to cause an initial flare-up in patients suffering from severe acne.

摘要

引言

痤疮在青春期出现,部分原因是激素和生长因子水平升高,这些因素刺激初级皮脂腺细胞中的从头脂肪生成(DNL),从而显著增加皮脂分泌。口服异维A酸是一种有效的痤疮治疗药物,通过诱导皮脂腺细胞凋亡来减少皮脂分泌。然而,异维A酸具有致畸性,还有其他不良副作用,包括最初的痤疮爆发,这限制了它的应用。双胍类药物二甲双胍已被发现可通过使患有多囊卵巢综合征(PCOS)的女性的胰岛素和雄激素水平正常化来缓解严重痤疮。二甲双胍在非PCOS人群中改善痤疮的更广泛有效性缺乏显著的临床支持。为了确定双胍类药物是否直接影响皮脂生成,我们在体外细胞实验中研究了它们改变DNL的能力。

方法

使用[14C] - 乙酸盐标记法在人原代皮脂腺细胞中测量从头脂肪生成。通过提取新合成的脂质并对其进行薄层色谱分析来进行脂质种类分析。通过对分离的RNA进行qPCR分析来鉴定皮脂腺细胞中的基因表达变化。在人原代皮脂腺细胞中评估包括耗氧率、乳酸产生和单磷酸腺苷依赖性蛋白激酶(AMPK)激活在内的代谢参数。

结果

使用人原代皮脂腺细胞,我们发现双胍类药物、异维A酸和阿奇霉素可诱导中性脂质的[14C] - 乙酸盐标记出现急性剂量和时间依赖性增加,而AMPK激活剂AICAR则抑制这种DNL反应。双胍类药物在皮脂腺细胞中未激活AMPK,然而,它们显著降低了耗氧率并增加了乳酸产生。用双胍类药物而非异维A酸处理可显著上调原代皮脂腺细胞中ACSS2基因的表达,并与脂肪生成激活剂协同诱导DNL基因。

讨论

这些变化与皮脂腺细胞脂肪生成的急性增加一致,并支持双胍类药物可能导致重度痤疮患者最初爆发的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/514b/7048953/6bcc8bdb5d3a/CCID-13-197-g0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验